Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot hypoglycemic clamp recovery study
2025-520996-16-00Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of insulin aspart in type 2 diabetes mellitus (T2DM) (2 cohorts), sponsored by Medical University of Graz. Primary endpoint: Ratio of insulin rates required for two hypoglycemic steps. Started Jun 2025; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2025-520996-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520996-16-00.